Perspective Therapeutics
CATX
26 hedge funds and large institutions have $4.02M invested in Perspective Therapeutics in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 7 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 2
0% less ownership
Funds ownership: 0.78% → 0.78% (-0%)
13% less funds holding
Funds holding: 30 → 26 (-4)
33% less capital invested
Capital invested by funds: $6.01M → $4.02M (-$1.99M)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$75.1K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$41.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$36.4K |
| 4 |
LPL Financial
San Diego,
California
|
+$23.7K |
| 5 |
Goldman Sachs
New York
|
+$14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$101K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
-$56K |
| 3 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
-$42.1K |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$16K |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$14K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SIM
26
Sonora Investment Management
Tucson,
Arizona
| $5K | +$6.23K | +500 | New |
|
|
27
AQR Capital Management
Greenwich,
Connecticut
| – | -$101K | -7,216 | Closed |
|
|
28
Creative Planning
Overland Park,
Kansas
| – | -$56K | -4,000 | Closed |
|
|
29
Nomura Holdings
Tokyo,
Japan
| – | -$16K | -1,100 | Closed |
|
30
Morgan Stanley
New York
| – | -$14K | -1,040 | Closed |
|
|
GC
31
Guggenheim Capital
Chicago,
Illinois
| – | -$14K | -1,018 | Closed |
|
|
JIC
32
Joel Isaacson & Co
New York
| – | -$7K | -500 | Closed |
|
33
Citigroup
New York
| – | -$1K | -50 | Closed |
|
CATX Hedge Fund Activity: Q4 2015 in Review
26 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q4 2015, worth a combined $4.02M — down 33% from $6.01M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of CATX and 3 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 8 added.
The largest buyer was Bridgeway Capital Management, adding an estimated $75.1K. The largest seller was AQR Capital Management, exiting entirely with an estimated $101K sold.
- 26 institutional investors held Perspective Therapeutics (CATX) as of Q4 2015, down from 30 in Q3 2015.
- Funds reported $4.02M of Perspective Therapeutics stock for Q4 2015, down 33% quarter-over-quarter.
- 3 funds opened new Perspective Therapeutics positions in Q4 2015 and 7 closed out, a net change of -4 holders.
- The largest Perspective Therapeutics buyer in Q4 2015 was Bridgeway Capital Management, an estimated $75.1K added.
- The largest Perspective Therapeutics seller in Q4 2015 was AQR Capital Management, an estimated $101K sold.
Based on aggregated 13F filings for Q4 2015.